dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Figlioli, Gisella |
dc.contributor.author | Bogliolo, Massimo |
dc.contributor.author | Catucci, Irene |
dc.contributor.author | Caleca, Laura |
dc.contributor.author | Lasheras, Sandra Viz |
dc.contributor.author | Pujol, Roser |
dc.contributor.author | Balmaña Gelpí, Judith |
dc.contributor.author | Diez Gibert, Orland |
dc.date.accessioned | 2021-03-23T14:42:57Z |
dc.date.available | 2021-03-23T14:42:57Z |
dc.date.issued | 2019-11-01 |
dc.identifier.citation | Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, et al. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. npj Breast Cancer. 2019 Dec 1;5(1):1–14. |
dc.identifier.issn | 2374-4677 |
dc.identifier.uri | https://hdl.handle.net/11351/5790 |
dc.description | Cáncer de mama; Genética del cáncer |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation.ispartofseries | npj Breast Cancer;5 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | Càncer - Aspectes genètics |
dc.subject.mesh | Triple Negative Breast Neoplasms |
dc.subject.mesh | /genetics |
dc.title | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41523-019-0127-5 |
dc.subject.decs | neoplasias de mama triple negativos |
dc.subject.decs | /genética |
dc.relation.publishversion | https://www.nature.com/articles/s41523-019-0127-5 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Figlioli G, Catucci I] IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy. [Bogliolo M, Pujol R] Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain. Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain. [Caleca L] Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy. [Lasheras SV] Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. [Balmaña J] High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Diez O] Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Genètica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 31700994 |
dc.identifier.wos | 000493912600001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/RTI2018-098419-B-I00 |
dc.relation.projectid | info:eu-repo/grantAgreement/EC/FP7/HEALTH-F5-2012-305421 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |